Homoeopathy for painful diabetic neuropathy

AN OPEN CLINICAL TRIAL: ROLE OF HOMOEOPATHIC TREATMENT IN PAINFUL DIABETIC NEUROPATHY USING SYNTHESIS REPERTORY

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021698

Enrollment

Registered

2019-10-17

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Individualized Homoeopathic Medicines: Intervention is planned as administering indicated homoeopathic remedies in centesimal and 50-millesimal scale. In centesimal scale each dose is c

dosage and repetition depending upon the individual requirement of the case. In 50-millesimal scale one globule of no.10 is to be dissolved in 120 ml of distilled water, 5 minims of rectified spirit i

dosage and repetition depending upon the individual requirement of the case. All medicines will be produced from a Good Manufacturing practice (GMP) certified firm. Control Intervention1: No active co

Eligibility

Inclusion criteria

Inclusion criteria: Person not taking any other homoeopathic medicines for last 6 weeks. Literate patients, ability to read Bengali, and/or English and capability to give informed consent and to comply with the study procedure.

Exclusion criteria

Exclusion criteria: i.Other kinds of Diabetic neuropathy or neuropathy due to other causes. ii.Person suffering from any other neurological disorders. iii.Development of typical Charcot joints, particularly in the feet. iv.Complication of Diabetes (retinopathy, renal involvement or with history of recurrent acute complaints like hypoglycaemia, keto-acidosis). v.Person suffering from any other chronic debilitating diseases. vi.Person suffering from any psychiatric disorder. vii.Lactating mothers. viii.Immuno-compromised patients. ix.Person taking homoeopathic medicine for any other cause.

Design outcomes

Primary

Measure	Time frame
Visual analogue scale (VAS) for painTimepoint: At baseline and after 3 months	—

Secondary

Measure	Time frame
SF-36 QuestionnaireTimepoint: At baseline and after 3 months	—

Countries

India

Contacts

Public ContactShubhamoy Ghosh

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital

shubhamoy67@gmail.com9831034229

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026